• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗心肌梗死的先进的生物活性水凝胶。

Advanced bioactive hydrogels for the treatment of myocardial infarction.

机构信息

College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350108, People's Republic of China.

College of Chemistry, Fuzhou University, Fuzhou, 350108, People's Republic of China.

出版信息

J Mater Chem B. 2022 Oct 26;10(41):8375-8385. doi: 10.1039/d2tb01591a.

DOI:10.1039/d2tb01591a
PMID:36227280
Abstract

Myocardial infarction (MI) is the leading cause of cardiovascular disease-related deaths. Local ischemia and cardiomyocyte death lead to a series of pathological remodeling events of the infarcted extracellular matrix (ECM) that are significantly different from normal cardiac tissues. These pathological characteristics have inspired the development of microenvironment-responsive therapeutic strategies for MI. Bioactive hydrogels attract great attention because of their unique physicochemical features to induce specific biological responses upon interacting with cells, ECMs, and signal molecules. They exhibit physicochemical-responsive activities to regulate interactions between hydrogels and the biological system. Many bioactive hydrogels with intelligent properties have been used to repair infarcted myocardium and restore the cardiac function after MI. Current research studies ensure that bioactive hydrogels have a high clinical importance and application prospects. This review summarizes the advances of bioactive hydrogels in the field of on-demand treatment of MI and evaluates their key physicochemical characteristics. A range of bioactive hydrogels and their biomedical applications are discussed in repairing injured hearts and restoring cardiac functions, providing insights into the development of intelligent therapeutic approaches for MI.

摘要

心肌梗死(MI)是心血管疾病相关死亡的主要原因。局部缺血和心肌细胞死亡导致梗死细胞外基质(ECM)的一系列病理重塑事件,这些事件与正常心脏组织显著不同。这些病理特征激发了针对 MI 的微环境响应治疗策略的发展。生物活性水凝胶因其独特的物理化学特性而受到极大关注,这些特性在与细胞、ECM 和信号分子相互作用时会诱导特定的生物学反应。它们表现出物理化学响应活性,以调节水凝胶与生物系统之间的相互作用。许多具有智能特性的生物活性水凝胶已被用于修复梗死心肌并恢复 MI 后的心脏功能。目前的研究确保了生物活性水凝胶具有很高的临床重要性和应用前景。本综述总结了生物活性水凝胶在 MI 按需治疗领域的进展,并评估了它们的关键物理化学特性。讨论了一系列生物活性水凝胶及其在修复受损心脏和恢复心脏功能方面的生物医学应用,为 MI 的智能治疗方法的发展提供了新的见解。

相似文献

1
Advanced bioactive hydrogels for the treatment of myocardial infarction.用于治疗心肌梗死的先进的生物活性水凝胶。
J Mater Chem B. 2022 Oct 26;10(41):8375-8385. doi: 10.1039/d2tb01591a.
2
Chemically Programmed Hydrogels for Spatiotemporal Modulation of the Cardiac Pathological Microenvironment.化学程序化水凝胶用于心脏病变微环境的时空调节。
Adv Mater. 2024 Aug;36(32):e2404264. doi: 10.1002/adma.202404264. Epub 2024 Jun 11.
3
Insight into Heart-Tailored Architectures of Hydrogel to Restore Cardiac Functions after Myocardial Infarction.深入了解用于心肌梗死后恢复心脏功能的水凝胶心脏定制结构。
Mol Pharm. 2023 Jan 2;20(1):57-81. doi: 10.1021/acs.molpharmaceut.2c00650. Epub 2022 Nov 22.
4
Biotherapeutic-loaded injectable hydrogels as a synergistic strategy to support myocardial repair after myocardial infarction.载生物治疗剂的可注射水凝胶作为心肌梗死后支持心肌修复的协同策略。
J Control Release. 2021 Jul 10;335:216-236. doi: 10.1016/j.jconrel.2021.05.023. Epub 2021 May 20.
5
Biohybrid cardiac ECM-based hydrogels improve long term cardiac function post myocardial infarction.基于生物杂交心脏细胞外基质的水凝胶可改善心肌梗死后的长期心脏功能。
Acta Biomater. 2017 Mar 1;50:220-233. doi: 10.1016/j.actbio.2016.12.015. Epub 2016 Dec 9.
6
Anisotropic conductive reduced graphene oxide/silk matrices promote post-infarction myocardial function by restoring electrical integrity.各向异性导电还原氧化石墨烯/丝素基质通过恢复电完整性促进梗死后心肌功能。
Acta Biomater. 2022 Feb;139:190-203. doi: 10.1016/j.actbio.2021.03.073. Epub 2021 Apr 6.
7
Progresses and perspectives on natural polysaccharide based hydrogels for repair of infarcted myocardium.天然多糖水凝胶修复梗死心肌的研究进展与展望。
Int J Biol Macromol. 2024 Jun;269(Pt 2):132213. doi: 10.1016/j.ijbiomac.2024.132213. Epub 2024 May 8.
8
Cell or cell derivative-laden hydrogels for myocardial infarction therapy: from the perspective of cell types.细胞或细胞衍生物负载水凝胶治疗心肌梗死:从细胞类型的角度。
J Mater Chem B. 2023 Oct 25;11(41):9867-9888. doi: 10.1039/d3tb01411h.
9
Advances in Injectable Hydrogel Strategies for Heart Failure Treatment.用于心力衰竭治疗的可注射水凝胶策略的进展。
Adv Healthc Mater. 2023 Jul;12(19):e2300029. doi: 10.1002/adhm.202300029. Epub 2023 Mar 27.
10
Sustained Release of a Peptide-Based Matrix Metalloproteinase-2 Inhibitor to Attenuate Adverse Cardiac Remodeling and Improve Cardiac Function Following Myocardial Infarction.基于肽的基质金属蛋白酶-2抑制剂的缓释可减轻心肌梗死后的不良心脏重塑并改善心脏功能。
Biomacromolecules. 2017 Sep 11;18(9):2820-2829. doi: 10.1021/acs.biomac.7b00760. Epub 2017 Aug 7.

引用本文的文献

1
Reactive oxygen species-responsive hydrogel loaded with melatonin as a minimally invasive treatment for myocardial I/R injury.负载褪黑素的活性氧响应水凝胶作为心肌缺血/再灌注损伤的微创治疗方法
iScience. 2025 Jun 6;28(7):112834. doi: 10.1016/j.isci.2025.112834. eCollection 2025 Jul 18.
2
Application of Pro-angiogenic Biomaterials in Myocardial Infarction.促血管生成生物材料在心肌梗死中的应用
ACS Omega. 2024 Aug 27;9(36):37505-37529. doi: 10.1021/acsomega.4c04682. eCollection 2024 Sep 10.
3
Hydrogel-based cardiac repair and regeneration function in the treatment of myocardial infarction.
基于水凝胶的心脏修复与再生功能在心肌梗死治疗中的应用
Mater Today Bio. 2024 Feb 13;25:100978. doi: 10.1016/j.mtbio.2024.100978. eCollection 2024 Apr.
4
Evaluation of Tyrosine Kinase Inhibitors Loaded Injectable Hydrogels for Improving Connexin43 Gap Junction Intercellular Communication.评价载酪氨酸激酶抑制剂的可注射水凝胶以改善缝隙连接蛋白 43 细胞间通讯。
ACS Appl Mater Interfaces. 2024 Jan 17;16(2):1985-1998. doi: 10.1021/acsami.3c10923. Epub 2024 Jan 4.
5
HSP90-Dependent Upregulation of EZH2 Promotes Hypoxia/Reoxygenation-Induced Pyroptosis by Inhibiting miR-22 in Endothelial Cells.热休克蛋白90依赖的EZH2上调通过抑制内皮细胞中的miR-22促进缺氧/复氧诱导的焦亡。
J Inflamm Res. 2023 Jun 19;16:2615-2630. doi: 10.2147/JIR.S403531. eCollection 2023.